• DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
  • DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
Home > Our people > Leadership > Regional leaders
Eric Stobbaerts

Eric Stobbaerts

International Development Director, DNDi

  • Eric Stobbaerts
  • @ericstobbaerts.bsky.social
  • @EricStobbaerts

Established in Brazil, Eric joined DNDi to lead a global campaign on Chagas disease “Time to treat” in 2009. He became the Regional Executive Director for DNDi Latin America in January 2010 for six consecutive years. Under his leadership, the office expanded its influence in Latin America, contributing to widening effective partnerships in the field of neglected diseases and facilitating strong public engagement from key countries particularly in Brazil, Argentina, Colombia, Mexico, and Bolivia. This collective effort paved the way to new ways of engagement by contributing to countrywide and regional agenda for innovation in the field of science and health technologies.

Part of the global team, Eric is now based in London advising the DNDi international network of seven offices around the globe (Tokyo, Kuala Lumpur, New Delhi, Kinshasa, Nairobi, Rio de Janeiro, and New York). Together with the offices leaders, he guides international development with a strategic focus on fostering public and private collaborations in low- and middle-income countries and co-creating sustainable solutions for neglected patients around the globe.

For 20 years, Eric worked with Médecins Sans Frontières as Head of Mission in several crisis affecting for civilian populations in danger (Lebanon, Afghanistan and Pakistan, Iraq, former Yugoslavia, Indonesia, Egypt, and the MENA region) and was part of MSF emergency response unit. In 1998, he took over the direction of MSF in Spain, one of five MSF Operational Centres, and led its successful development until 2004. He was part of the MSF international delegation to travel to Oslo for the Nobel Peace Prize (1999) that led to the creation of DNDi. From 2004 onwards, he consulted for the international office of MSF and several international NGOs in London. He led the set-up of new entities of MSF outside of Europe: particularly in Brazil and South Africa. He served on several Board of Directors of MSF and DNDi.

Brought up in a multi-cultural environment, Eric holds an MBA from the University of Geneva after completing studies in Economics and Public Affairs at the University of Louvain and in Public Health.

Featured news & publications

Loading...
  • Estimación de la demanda de medicamentos antichagásicos: Una contribución para el acceso en América Latina (Estimating demand for anti-Chagas drugs: a contribution for access in Latin America)
  • The BENEFIT Trial: Where do we go from here?
  • Target Product Profile (TPP) for Chagas disease point-of-care diagnosis and assessment of response to treatment
  • Chagas Disease in Colombia: An opportunity to lead the way towards change
  • The Role of Neglected Disease-Endemic, Emerging-Economy Countries in Neglected Disease R&D: Latin America on the Rise
Loading...

Our global footprint

Loading...
Doctors talking with patient in hospital

DNDi DRC

Female healthcare worker taking care of a little girl

DNDi Eastern Africa

DNDi Japan

Female patient discussing with doctor

DNDi Latin America

Female doctor with a patient in a hospital

DNDi North America

Community worker talking with people in a rural village

DNDi South Asia

Malaysian doctor talking with a man in a hospital

DNDi South-East Asia

Two people speaking in an office

DNDi Switzerland

Stay connected

Get our latest news, personal stories, research articles, and job opportunities. 

Linkedin-in Instagram Twitter Facebook-f Youtube
International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Learn more

  • Diseases
  • Neglected tropical diseases
  • R&D portfolio
  • Policy advocacy

Get in touch

  • Our offices
  • Contact us
  • Integrity Line

Support us

  • Donate
  • Subscribe to eNews

Work with us

  • Join research networks
  • Jobs
  • RFPs
  • Terms of Use   
  •   Acceptable Use Policy   
  •   Privacy Policy   
  •   Cookie Policy   
  •   Our policies   

  • Except for images, films and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 3.0 Switzerland License